AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports - Reuters

Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports - Reuters

Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports Reuters

March 7, 2026 at 01:04 AM Original source
2 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
1 articles
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

C
Carlos MéndezJournalist

Carlos Méndez is a journalist reporting from Mexico City.

Locations

denmark Mexico City, Mexico USA

Tags

business partnership drugs feud health healthcare hims novo obesity obesity drugs partnership pharmaceuticals weight loss

All Coverage

Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxNdXNlT2JONFFqbVlvbHRJQlRZQkc4MXFjcGlobnVyYklCZzlKdnpQMkYtaUp4enVqVGNUTjZ6SWJMLW5XWjB2Wk1YZ2tMTm42Mi1pVDVYcUI4ZGRRTkJ3bWtETmxWejNHd3pqbWVjMUxMN3JCM05aa1ZoTkszNEdMUXZYc202Uk80QzFkcUNyZVJjM2ZLM01uZDNHeTlZTXlXOEFmS2Q2WWc2OG5KR3Q5M3pyQVpCYTd5M3JwclZUMVlNSE1ZeHJXc1pEelpoQ2xaQ2Rxbl9wa2pOeTM2ZFE?oc=5" target="_blank">Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%
Novo and Hims resolve dispute, will sell obesity drugs together, Bloomberg News reports
Yahoo! Newsvia ai

Novo Nordisk plans to sell its weight-loss drugs on Hims & Hers Health platform, ending a dispute that escalated into a legal battle last month.

80%

Similar Stories

Related coverage based on topic and tags

South African regulators issue recall of Ozempic copies - Reuters

South African regulators issue recall of Ozempic copies Reuters

July 9, 2026 at 09:14 PM

India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice - Reuters

India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice Reuters

July 9, 2026 at 12:23 PM

India's Dr Reddy's delays semaglutide supply, loses $678 mln in market value - Reuters

India's Dr Reddy's delays semaglutide supply, loses $678 mln in market value Reuters

July 9, 2026 at 04:54 AM

AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports - Reuters

AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports Reuters

July 8, 2026 at 06:34 PM

CVS settles with FTC, agrees to count TrumpRx drug purchases towards insurance - Reuters

CVS settles with FTC, agrees to count TrumpRx drug purchases towards insurance Reuters

July 14, 2026 at 07:31 PM

GSK's Jemperli meets main goal in mid-stage rectal cancer trial - Reuters

GSK's Jemperli meets main goal in mid-stage rectal cancer trial Reuters

July 13, 2026 at 06:45 PM